The Lynx Group

Conference Correspondent

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

Conference Correspondent — December 2, 2020
Cancer care is complex and expensive, making a one-size-fits-all approach to drug benefit designs and coverages an unfavorable solution for patients with cancer. In this session, panelists discuss drug benefit reforms and the intended and unintended consequences of the recommended provisions.
Read Article

Conference Correspondent — December 1, 2020
With multiple stakeholders playing a key role in value-based contracting, the pharmaceutical industry faces many obstacles. In this session, experts discuss these obstacles and the strategies for overcoming them.
Read Article

Conference Correspondent — November 30, 2020
340B is a discount program for low-income areas that increases resources and allows for patient expansion. In this session, panelists discuss the accuracy of pricing, the current state of the program, and future developments.
Read Article

Conference Correspondent — November 24, 2020
In this session, industry leaders discuss defining clinical utility for genomic testing and make recommendations to ensure appropriate implementation in cancer care.
Read Article

Conference Correspondent — November 23, 2020
Technology can enhance the patient engagement experience, creating a willingness among patients to receive advice and counseling virtually. In this session, experts discuss the challenges of engaging patients and the future of technology in the healthcare system as it relates to cancer care.
Read Article

Conference Correspondent — November 20, 2020
No one truly knows what it is like to navigate cancer until they are diagnosed with the disease. In this session, survivors shared their stories and messages of hope as we prepare for Thanksgiving.
Read Article

Conference Correspondent — November 19, 2020
Depending on the stakeholder’s point of view, value-based contracting can have many definitions and meanings. In this session, experts from across the healthcare continuum explore what is working, what has failed, and what lessons have been learned regarding value-based contracting.
Read Article

Conference Correspondent — November 18, 2020
Designing and implementing value-based contracts is a challenge to stakeholders across the cancer care ecosystem. In this discussion, panelists analyze the future of these contracts and precision medicine.
Read Article

Conference Correspondent — November 17, 2020
During the COVID-19 pandemic, telehealth has been considered a silver lining in that it has allowed increased access to care. In this session, experts discuss the early challenges of telehealth and how it can improve the future of cancer care.
Read Article

Conference Correspondent — November 16, 2020
The COVID-19 pandemic has had many devastating effects beyond the spread of the disease, and these effects have led to important lessons in the healthcare system. In this session, experts discuss key takeaways from the pandemic and the future of cancer care in the new normal.
Read Article

Page 2 of 41

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to receive the free VBCC print publication or weekly e‑Newsletter.

I'd like to receive: